Introduction. Pediatric Brain Tumors: Current Concepts. Epidemiology. Clinical Features. I - Posterior Fossa

Introduction Pediatric Brain Tumors: Current Concepts Nalin Gupta Division of Pediatric Neurosurgery Departments of Neurosurgery and Pediatrics Univer...
Author: Oliver Fowler
7 downloads 0 Views 991KB Size
Introduction Pediatric Brain Tumors: Current Concepts Nalin Gupta Division of Pediatric Neurosurgery Departments of Neurosurgery and Pediatrics University of California San Francisco

• Brain and spinal cord tumors are the second most common malignancy in children • Outcome is often dependent on several factors **Degree of resection Location. Benign tumors in critical locations are often unresectable Histological grade

Epidemiology • Uncommon. Incidence is 2-5/100,000 ~3000 new cases in the US annually

• No sex predominance, although variations exist between histological types • Metastatic lesions are very rare

Clinical Features • Children have different patterns of clincal presentations; often a function of location I II III

Posterior fossa tumors Low grade hemispheric tumors Sellar region

I - Posterior Fossa • Signs and Symptoms Headache (morning) Nausea Projectile vomiting Drowsiness and lethargy Diplopia Ataxia Papilledema

POSTERIOR FOSSA SYNDROME

1

Epidemiology

Posterior Fossa Tumors

• Distribution varies between different cranial comparments supratentorial infratentorial spinal

54% 41 5

Cerebellar Astrocytoma (JPA) • Peak incidence is between 6-8 yrs of age • No sex predilection • Headache is the presenting symptom in ~90% of cases; vomiting in ~80% • Histologically benign • Gross surgical resection is curative

Surgical Principles

PNET (medulloblastoma) 25-30% Cerebellar astrocytoma (JPA) 25% Ependymoma 15%

Surgical Principles Gross Total Resection Pre-op surgical considerations a) symmetric vs. asymmetric b) cystic vs mainly solid c) relationship to vermis (rostral to caudal) d) relationship to 4th ventricle

Surgical Principles

Craniotomy two burr holes either side of midline and two at foramen magnum superior edge at inferior edge of transverse sinus (extend craniectomy above) width: at least 4 cm

Drain the cyst early Maintain the boundary! If the cyst wall is substantial, resect Preserve the vermis

2

1 3 3

1 2

4

Other Considerations Fourth ventricle Non-enhancing cyst wall Differential diagnosis PNET ganglioglioma ependymoma hamartoma

Residual Disease If resection is possible, re-operation warranted If small residual, unresectable, close observation warranted

4

2

Complications Vermian injury (mutism) New neurological signs in up to 40% CSF leak Hydrocephalus Brainstem injury * Residual tumor

Grade II Astrocytomas Infrequently in cerebellar location (I: 85-90%; II: 10-15%; III-IV:

Tectal Glioma

Pons

>

Diffuse infiltrative

Medulla

>

JPA

Technical Considerations Relationship to key structures; complication avoidance Anatomical corridor Working distance

Midbrain Location Tectal lesions usually display an indolent profile Tegmental lesions are usually JPAs but can also resemble a thalamic profile Patterns of growth are unpredictable and surgery may be required

Case 1 6 y/o girl presenting with progressive leftsided weakness Clumsiness, weakness of left side with upper motor neuron features. No cranial neuropathy

6

Management Diagnosis? Favor stereotactic biopsy to exclude the diagnosis of PNET

Management Diagnosis? Favor stereotactic biopsy to exclude the diagnosis of PNET Biopsy

Comparison - OZ Approach Pros OZ craniotomy shorter reach familiar anatomy

Cons obstructing vessels and nerves upward and downward reach is reduced

>

JPA

Comparison - Transcallosal Transcallosal long axis of tumor ‘pure’ anatomy long reach limits of large tumor difficult to reach

7

Case 2 3 y/o girl with progressive difficulty walking and right sided weakness

8

Case 3 11 y/o boy with progressive right-sided weakness Stereotactic biopsy: grade II astrocytoma

1

2

3

Summary High brainstem tumors are surgically accessible Safe decompression is possible Gross total resection is difficult with large tumors Tools are suboptimal

9

II - Hemispheric Tumors • Signs and Symptoms seizures headache, nausea, vomiting focal weakness or hemiparesis personality change visual loss (common sign is papilledema)

Hemispheric Tumors • 30% are low grade astrocytomas incidence is 5/1 million children

• 30% are a conglomerate of low grade glial, neuronal, and mixed tumors gangliogliomas, DNET

• 20% are malignant tumors (PNET) • Other (ependymomas)

Hemispheric Astrocytoma • Outcome determined by: tumor histology, extent of resection, location

• 5 yr survival with subtotally resected low grade gliomas is 90% low grade tumors may remain quiescent

• Controversies adjuvant therapy (chemotherapy before radiotherapy) treatment of epilepsy radiotherapy modality

Hemispheric Astrocytoma

High Grade Glioma

• Current approach Deferral of radiation in children < 5 years Randomized study of chemotherapy (CCGA9952) Carboplatin/Vincristine vs. 6TG/CCNU/Procarbazine/Vincristine

10

III - Sellar Region • Signs and Symptoms Visual change (field deficits, blindness) Endocrine abnormalities growth failure failure of secondary sexual maturity hypothyroidism diabetes insipidus

Drowsiness and lethargy Papilledema

Sellar Region • Optic pathway gliomas can be indolent and long term survival is common • 65% occur in first 5 years of life • Majority involve the chiasm and hypothalamus • Strongly associated with NF1 • Excellent results reported with certain chemotherapy regimes

Surgical Adjuncts

MRI: 9/17/01

Left 5th MSI: 10/1/01 Left Index

Right Thumb

Neuronavigation Greatly improved imaging

slow wave

Functional Mapping and Imaging Intraoperative monitoring facial nerve, hypoglossal nerve SSEP, MEP

11

T1

T2

Perfusion

Subcortical Motor Tractography

MR Spectroscopy

Brain Mapping - Subdural Grids

MRI with MRS Map MRI with MRS grid

MRS Map

Brain Mapping

Brain Mapping

12

PDGF

Molecular Features TUMOR TYPE Pilocytic astrocytoma

CHROMOSOMAL ALTERATIONS del 17q

EGF

PI3K

IMPLICATED GENES

PI3K

o o o o

ZD1839

P

NF1

STI571

Ras

P

Ras

P P

Astrocytoma

Brainstem glioma Medulloblastoma Atypical Teratoid/Rhabdoid

LOH 17p (GBM)

LOH 17p LOH 10p del 9q22

EGFR PTEN P16, CDK4, Rb AGT, MMR p53

R115777

PTEN

PDK-1

OSI-774

R115777

PKB mTOR

Ptch, TrkC, ErbB2 INI1

CCI-779 p70S6K

Summary • Outcome is better than in adults (due to biology rather than treatment)

• Development of ‘rational’ therapeutics • Cognitive outcome after treatment is a major concern • Second malignancy rate - 11.3%

13

Suggest Documents